Long-acting Reversible Contraceptive (LARC)

How to talk with patients about how long IUDs and implants work, and what to say when the evidence goes beyond the FDA label.

What providers need to know about safety and contraceptive decision-making for patients with autoimmune conditions

What providers need to know about placing a levonorgestrel intrauterine device (LNG-IUD) after unprotected sex

Review of evidence-based, person-centered strategies for improving patient comfort during IUD placements, from paracervical blocks to non-medication supports

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.

Clinical trial data on a new IUD, clinical guidance on self-managed abortion, the impact of the ACA on reproductive health, and CDC’s abortion surveillance data.

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Ongoing support for forgoing Rh testing in early pregnancy, medication abortion before six weeks, provider bias on contraceptive counseling adolescents, and local anesthesia before procedural abortion.